Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

CJC-1295 DAC.

Research draft

CJC-1295 DAC is a long-acting growth-hormone-releasing hormone analogue.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

CJC-1295 DAC is a long-acting growth-hormone-releasing hormone analogue.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

Its drug-affinity complex prolongs exposure through albumin binding, stimulating pituitary growth-hormone release.

Human research

Small studies in healthy adults showed increased growth hormone and IGF-1. This does not establish recovery, muscle-building or longevity benefits.

Preclinical & other research

Animal studies investigated growth responses and hormonal signalling.

Safety & unknowns

Sustained hormonal stimulation and reported cardiovascular reactions warrant caution; long-term wellness-use safety is not established.

Regulatory status

Investigational; keep separate from products sold as CJC-1295 without DAC.

Reported use & evidence

Research profile draft

The supplied CJC-1295 DAC profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds